AGK

AGK is a mitochondrial membrane-associated lipid kinase with dual kinase-dependent and kinase-independent functions spanning lipid metabolism, mitochondrial protein import, signal transduction, and platelet biology. As a multi-substrate lipid kinase, AGK phosphorylates diacylglycerol, monoacylglycerol, and ceramide to generate phosphatidic acid and lysophosphatidic acid, with activity modulated by cardiolipin and divalent cations (PMID:15252046); it also serves as a structural subunit of the TIM22 inner mitochondrial membrane protein import complex, where AGK mutations impair OXPHOS complex I and V activity (PMID:34948281). Independent of its kinase activity, AGK binds JAK2 via a kinase-independent interaction to support megakaryopoiesis and thrombopoietin-driven JAK2/STAT3 signaling, and interacts with complex I subunits NDUFS2/NDUFA10 to maintain mitochondrial respiratory chain integrity (PMID:32202634, PMID:35547757). AGK also functions as a protein kinase that phosphorylates Talin-1 at Ser425 to regulate αIIbβ3 integrin bidirectional signaling in platelets, and can be palmitoylated by ZDHHC2 to relocalize to the plasma membrane where it activates PI3K-AKT-mTOR signaling (PMID:37051931, PMID:37078777).

1. 2004 High

   The fundamental enzymatic identity of AGK was established as a multi-substrate lipid kinase with broad specificity toward diacylglycerol, ceramide, and monoacylglycerol, resolving its biochemical activity and membrane association.

   Evidence In vitro enzymatic assay with recombinant AGK, substrate specificity profiling, subcellular fractionation

   PMID:15252046

   Open questions at the time

   • Physiological lipid substrates in vivo not determined
   • Subcellular membrane compartment identity not resolved beyond 'internal membranes'
   • No structural model of the active site
2. 2014 Medium

   AGK was linked to oncogenic signaling beyond lipid metabolism, with overexpression in hepatocellular carcinoma activating NF-κB signaling to promote angiogenesis and inhibit apoptosis.

   Evidence AGK overexpression and knockdown in HCC cell lines, xenograft model, NF-κB pathway analysis

   PMID:25474138

   Open questions at the time

   • Direct biochemical mechanism linking AGK to NF-κB not established
   • Unclear whether lipid kinase activity is required for NF-κB activation
   • Single study without independent replication
3. 2019 Medium

   AGK was shown to regulate CD8+ T cell metabolism and antitumor function through inactivation of PTEN and enhancement of mTOR activity, revealing a role in adaptive immunity.

   Evidence Genetic loss-of-function and overexpression in CD8+ T cells, PTEN/mTOR signaling analysis

   PMID:31390548

   Open questions at the time

   • Mechanism of PTEN inactivation by AGK not biochemically defined
   • Whether lipid kinase products or a kinase-independent function drives the effect is unknown
4. 2020 High

   A major conceptual advance established that AGK has kinase-independent scaffolding functions: AGK binds JAK2 in megakaryocytes independent of its kinase activity to support thrombopoiesis, and the JAK2 V617F oncogenic mutation enhances this interaction, linking AGK to myeloproliferative signaling.

   Evidence Reciprocal Co-IP, megakaryocyte/platelet-specific AGK knockout and kinase-dead G126E knock-in mice, platelet functional assays

   PMID:32202634

   Open questions at the time

   • Structural basis of AGK-JAK2 interaction not resolved
   • Whether AGK-JAK2 interaction is direct or mediated by adaptor proteins not fully excluded
   • Role in human Sengers syndrome thrombopoiesis not addressed
5. 2021 Medium

   AGK was confirmed as a subunit of the TIM22 mitochondrial protein import complex, and patient-derived AGK mutations were shown to impair OXPHOS complex I and V activity, linking its structural role to mitochondrial bioenergetics.

   Evidence Patient fibroblast OCR/ECAR measurements, spectrophotometric OXPHOS complex activity assays, cDNA splicing validation

   PMID:34948281

   Open questions at the time

   • Which TIM22 substrates are specifically affected by AGK loss not catalogued
   • Relative contribution of lipid kinase versus TIM22 scaffold function to OXPHOS defects not dissected
   • Single patient variant studied
6. 2022 High

   The kinase-independent scaffolding concept was extended to the respiratory chain: AGK interacts with complex I subunits NDUFS2 and NDUFA10 via its DGK domain to maintain complex I function in hepatocytes, with AGK deficiency (but not kinase-dead mutation) causing NASH progression.

   Evidence Hepatocyte-specific AGK knockout and G126E knock-in mice, reciprocal Co-IP, dietary NASH models

   PMID:35547757

   Open questions at the time

   • Whether AGK-complex I interaction is direct or mediated through TIM22 import of complex I subunits is ambiguous
   • Stoichiometry and stability of AGK-NDUFS2/NDUFA10 complex not characterized
   • Relevance to human NASH not tested
7. 2023 High

   Two discoveries in 2023 expanded AGK's functional repertoire: ZDHHC2-mediated palmitoylation was shown to redirect AGK from mitochondria to the plasma membrane to activate AKT-mTOR signaling, and AGK was found to function as a protein kinase phosphorylating Talin-1 Ser425 to regulate integrin bidirectional signaling in platelets.

   Evidence Palmitoylation assay with subcellular fractionation and sunitinib resistance models (PMID:37078777); Co-IP/MS, phosphosite mapping, platelet-specific KO and kinase-dead KI mice with in vivo thrombosis assays (PMID:37051931)

   PMID:37051931 PMID:37078777

   Open questions at the time

   • Talin-1 phosphorylation by AGK not reconstituted with purified components
   • Palmitoylation-dependent relocalization not confirmed in non-cancer cell types
   • How AGK switches between lipid kinase and protein kinase activity is unknown
8. 2023 Medium

   AGK lipid products were linked to regulation of mitochondrial ion channels: AGK associates with ROMK2 in a proximity complex, and its products LPA and PA directly stimulate ROMK2 channel activity, suggesting localized lipid synthesis regulates channel function.

   Evidence TurboID proximity labeling, Co-IP, artificial lipid bilayer electrophysiology

   PMID:38056763

   Open questions at the time

   • Functional consequence of ROMK2 regulation by AGK-derived lipids in intact mitochondria not shown
   • Single study without genetic validation in cells
   • Whether AGK is obligate for ROMK2 activity or merely modulatory is unclear
9. 2025 Medium

   AGK-HSP90-JAK2 complex formation was demonstrated in CLL cells, driving constitutive cytokine-independent JAK2 activation and non-canonical histone H3Y41 phosphorylation with nuclear AGK-JAK2 co-localization, broadening AGK's scaffolding role to hematologic malignancy.

   Evidence Co-IP in primary CLL patient cells, nuclear fractionation, BCR signaling analysis

   PMID:39636206

   Open questions at the time

   • AGK-HSP90-JAK2 complex stoichiometry and directness of AGK-HSP90 interaction not resolved
   • Nuclear AGK localization observed only by fractionation, not by imaging
   • Single study in primary CLL cells without genetic manipulation of AGK

• How AGK coordinates its dual lipid kinase, protein kinase, and kinase-independent scaffolding activities — and what determines substrate selection and subcellular targeting — remains unresolved.
• No crystal structure or cryo-EM structure of AGK available
• Mechanism governing switch between lipid and protein kinase activities unknown
• Relative contributions of TIM22 scaffold vs. lipid kinase function to Sengers syndrome phenotype not dissected in vivo